Author:
Cengiz Murat,Sahinturk Pinar
Publisher
Springer Science and Business Media LLC
Subject
Drug Discovery,Pharmacology
Reference18 articles.
1. Cengiz, M. et al. Molecular characterization of quinolone resistance in Escherichia coli from animals in Turkey. Vet. Rec. 171, 155 (2012).
2. Hopkins, K. L., Davies, R. H. & Threlfall, E. J. Mechanisms of quinolone resistance in Escherichia coli and Salmonella: recent developments. Int. J. Antimicrob. Ag 25, 358–373 (2005).
3. Poirel, L. et al. Expanded-spectrum β-lactamase and plasmid-mediated quinolone resistance. Emerg. Infect. Dis. 13, 803–805 (2007).
4. Rodriguez-Martinez, J. M., Briales, A., Velasco, C., Martinez-Martinez, L. & Pascual, A. Discrepancies in fluoroquinolone clinical categoris between the European Committee on Antimicrobial Susceptibility Testing (EUCAST) and CLSI for Escherichia coli harbouring qnr genes and mutations in gyrA and parC. J. Antimicrob. Chemoth. 66, 1406–1453 (2011).
5. Blondeau, J. M., Borsos, S., Blondeau, L. D. & Blondeau, B. J. In vitro killing of Escherichia coli, Staphylococcus pseudintermedius and Pseudomonas aeruginosa by enrofloxacin in combination with its active metabolite ciprofloxacin using clinically relevant drug concentrations in the dog and cat. Vet. Microbiol 155, 284–290 (2012).
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献